Orchid Pharma Limited Stock Bombay S.E.
Equities
524372
INE191A01019
Pharmaceuticals
Sales 2024 * | 8.45B 101M 139M | Sales 2025 * | 10.78B 129M 178M | Capitalization | 55.64B 668M 917M |
---|---|---|---|---|---|
Net income 2024 * | 908M 10.91M 14.96M | Net income 2025 * | 1.42B 17.08M 23.42M | EV / Sales 2024 * | 6.46 x |
Net cash position 2024 * | 1.06B 12.68M 17.4M | Net cash position 2025 * | 1.2B 14.38M 19.72M | EV / Sales 2025 * | 5.05 x |
P/E ratio 2024 * |
60.8
x | P/E ratio 2025 * |
39.3
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 26.03% |
Latest transcript on Orchid Pharma Limited
Managers | Title | Age | Since |
---|---|---|---|
Manish Dhanuka
CEO | Chief Executive Officer | 56 | 20-03-30 |
Director of Finance/CFO | - | 20-06-28 | |
Kapil Dayya
CMP | Compliance Officer | - | 12-15 |
Members of the board | Title | Age | Since |
---|---|---|---|
Chairman | 74 | 20-03-30 | |
Mridul Dhanuka
BRD | Director/Board Member | 42 | 20-03-30 |
Manish Dhanuka
CEO | Chief Executive Officer | 56 | 20-03-30 |
1st Jan change | Capi. | |
---|---|---|
+38.11% | 723B | |
+34.28% | 595B | |
-4.46% | 369B | |
+20.12% | 332B | |
+2.80% | 282B | |
+17.02% | 244B | |
+9.31% | 208B | |
-5.07% | 205B | |
+0.02% | 168B |